Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Span Divergent

524727
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Span Divergent Share price and Fundamental Analysis

View All Details
View All Details
Incorporated on 31st March 1980 as Private Ltd. Co. and converted into a Public Ltd. Co. on 14th August 1993. Promoted by Dr.P.K.Desai. The Company is engaged in manufacturing a wide range of microbiological, immunological and bio-chemical diognostic reagents, plastic accessories and allied products in its plant at Udhna.
Company Incorporation1980
ChairmanN Gopalaswami
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
12.43
PE Ratio
0
Industry P/E
41.54
PEG Ratio
0
ROE
32.68%
ROCE
-8.25%
ROA
-5.47%
Total Debt (Cr)
2.23
Debt to Equity
-2.98
Dividend Yield
0%
EPS
0
Book Value & P/B
63.63 x 0.36
Face Value
10
Outstanding Shares(Cr)
0.55
Current Ratio
0.56
EV to Sales
2.31

Stock Returns

1 Week-5.13%
1 Month+9.8%
6 Months-28.19%
1 Year-18.75%
3 Years+27.09%
5 Years+116.87%
no_data

No Stocks

Smart Score

1.8
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone
PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Mar 25

Promoters : 64.00%

FIIs : 0.00%

DIIs : 0.00%

Public : 36.00%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Span Divergent Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Span Divergent Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Incorporated on 31st March 1980 as Private Ltd. Co. and converted into a Public Ltd. Co. on 14th August 1993. Promoted by Dr.P.K.Desai. The Company is engaged in manufacturing a wide range of microbiological, immunological and bio-chemical diognostic reagents, plastic accessories and allied products in its plant at Udhna.

The Company completed expansion-cum-modernisation and mechanisation of packing activities at Udhna. Acquiring three plots of land at GIDC Sachin admeasuring 33,897 sq. mtrs. which is situated near the State Highway and National Highway No.8.This project was finance by way of internal accruals of Rs.31.62 lakhs and balance from Term Loans of Rs.30 lakhs.

The Company entered into the technical arrangement with Bioprobe Netherland, Path U.S.A. Dynajen U.S.A. for manufacturing HIV Dipsticks, Myco-dot, Monoclonal anitbodies.

Company launched several new products developed by its R & D Center such as One Step Lateral Chromotography Based Assay for monitoring of pregnancy and Hepatitis to be marketed under the brand name of CRYSTAL as well as HIV Flow Through. The continuation distributorship arrangements with Murex Biotech UK Ltd which is now subsidiary of Abbott Diagnostics USA will also generate substantial business from the nitche market of the Blood Bank Segment.

Span Divergent Share Price

Span Divergent share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Span Divergent Market Cap

Market capitalization of Span Divergent indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Span Divergent is valued compared to its competitors.

Span Divergent PE Ratio

Span Divergent PE ratio helps investors understand what is the market value of each stock compared to Span Divergent 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Span Divergent PEG Ratio

The PEG ratio of Span Divergent evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Span Divergent ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Span Divergent generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Span Divergent ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Span Divergent in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Span Divergent Total Debt

Total debt of Span Divergent shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Span Divergent Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Span Divergent compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Span Divergent CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Span Divergent over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Span Divergent Technical Analysis

Technical analysis of Span Divergent helps investors get an insight into when they can enter or exit the stock. Key components of Span Divergent Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Span Divergent shares often struggle to rise above due to selling pressure.

Span Divergent Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Span Divergent ’s financial health and profitability.

Span Divergent Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Span Divergent Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Span Divergent Financials

The financials of Span Divergent provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Span Divergent Profit and Loss Statements

The profit and loss statement of Span Divergent highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Span Divergent .

Span Divergent Balance Sheet

The balance sheet presents a snapshot of Span Divergent ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Span Divergent Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App